期刊文献+

基于万古霉素手性柱的马来酸扑尔敏对映体分离及其识别机理

Chiral separation of chlorphenamine maleate on vancomycin-based stationary phase and chiral recognition mechanism
原文传递
导出
摘要 药物是环境介质中一类新型污染物,多数药物具有手性对映体特性,药物对映体的分离分析是研究对映体水平药物环境行为和效应的前提.采用商品手性柱Chirobiotic®V,在反相条件下,对马来酸扑尔敏进行了手性分离,考察了不同流速、柱温、pH值和流动相组成对分离的影响,并优化了色谱条件.结果表明:以含0.1%(体积分数)冰醋酸和0.1%(体积分数)三乙胺的水溶液(TEAA)与四氢呋喃(THF)混合为流动相,在所研究范围内,随着流动相中THF含量的增加、pH值增大和流速增大,马来酸扑尔敏对映体的分离效果降低;柱温影响存在峰值现象,即分离效果随温度的升高先增大后减小.优化得到的拆分条件为:流动相TEAA∶THF为95∶5(V/V),pH值为3,流速为0.3 mL·min^(-1),柱温为15℃.利用分子对接技术模拟万古霉素不同区域与扑尔敏对映体间的相互作用,计算得到了最稳定结合能,据此预测对映体的出峰顺序与实验结果完全一致.初步手性识别机理研究结果表明,引起手性识别的主要作用力为氢键作用. Pharmaceuticals are a large class of emerging pollutants in environmental matrix.It has been reported that more than 50%of these pharmaceuticals are chiral compounds.Thus,the chiral separation and analysis of pharmaceuticals are prerequisites for investigating environmental behavior and impact of drug enantiomers.The commercial vancomycin-bonded chiral stationary phase(CSP)combined with high performance liquid chromatography(HPLC)in reverse mode was used for the enantioseparation of chlorphenamine maleate enantiomers.The flow rate,column temperature,pH value and composition of mobile phase were optimized for the effective separation.The results showed that when TEAA containing 0.1%of glacial acetic acid and 0.1%of triethylamine(in volume ratio)was mixed with tetrahydrofuran(THF)as mobile phase,the reduced enantioresolution and selectivity were observed with an increased THF percentage,pH value and flow rate.The effect of column temperature on separation indicated that maximum values in enantioresolution and selectivity occurred at 15℃.As a result,the optimal chromatographic condition was:TEAA∶THF=95∶5(V/V),pH value of 3,flow rate of 0.3 mL·min-1,temperature of 15℃.Using molecular docking technique and binding energy calculations to simulate the interaction processes between chlorphenamine maleate and vancomycin,the magnitudes of steady combination energy(ΔG)was obtained,which coincided with experimental elution order of the enantiomers.The molecular docking results showed that the main retention mechanisms of chiral chlorphenamine maleate onto vancomycin were hydrogen bonding.
作者 李佳熹 王立阳 刘瑞霞 刘晓玲 高红杰 LI Jiaxi;WANG Liyang;LIU Ruixia;LIU Xiaoling;GAO Hongjie(Basin Research Center for Water Pollution Control,Chinese Research Academy of Environmental Sciences,Beijing 100012)
出处 《环境科学学报》 CAS CSCD 北大核心 2019年第3期774-779,共6页 Acta Scientiae Circumstantiae
基金 中央级公益性科研院所基本科研业务专项(No.JY-21277133)
关键词 马来酸扑尔敏 对映体分离 分离条件优化 分子对接方法 识别机制 chlorphenamine maleate enantioseparation chromatographic condition optimized molecular docking approach chiral recognition mechanism
  • 相关文献

参考文献3

二级参考文献23

  • 1于金刚,黄可龙,刘素琴,焦飞鹏,彭霞辉.高效液相色谱手性流动相添加剂法拆分氯噻酮对映体[J].分析试验室,2005,24(11):22-24. 被引量:11
  • 2Kussmaul WG Ⅲ, Buchbinder M, Whitlow PL, et al. Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: results of a randomized trial of a novel hemostatic device. J Am Coll Cardiol, 1995, 25:1685-
  • 3Leon MB, Baim DS, Popma J J, et al. A clinical trial comparing three antithrombotic drug regimens after coronary artery stenting. N Engl J Med, 1998, 339: 1665-1671.
  • 4Blankenship JC, Hellkamp AS, Aguirre FV, et al. Vascular access site complications after percutaneous coronary interventions with abciximab in the evaluation of c7E3 for the prevention of ischemic complications (EPIC trial). Am J Cardiol, 1998, 81: 36-40.
  • 5Aguirre FV, Topol E J, Ferguson J J, et al. Bleeding complications with the chimeric antibody to platelet glycoprotein lb/Ia integrin in patients undergoing percutaneous coronary intervention. Circulation, 1995, 91:2882-2890.
  • 6Silber S. Hemostasis success rates and local complications with collagen after femoral access for cardiac catheterization: analysis of 6007 published cases. Am Heart J, 1998, 135:152-156.
  • 7De Swart H, Dijkman L, Hofstra L, et al. A new hemostatic puncture closure device for the immediate sealing of arterial puncture sites. Am J Cardiol,1993, 72:445-449.
  • 8Silber S. 10 years of vascular closure devices: a critical analysis of their usefulness after PTCA. Z Kardiol, 2000, 89:383-389.
  • 9Eggebrecht H, Haude M, Baumgart D, et al. Infectious complications related to the use of the Angio-Seal hemostatic puncture closure device.Cathet Cardiovasc Intervent, 2000, 49: 352-353.
  • 10Da Shilu, Xu Wei, Dong Yaqiong. Chemistry (达世禄, 徐伟, 董亚琼. 化学通报), 1997, (2): 33

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部